EMA: EMA RECEIVES APPLICATION FOR CONDITIONAL MARKETING AUTHORISATION FOR PAXLOVID (PF-07321332 AND RITONAVIR) FOR TREATING PATIENTS WITH COVID-19: 10/01/2022